{"id":"https://genegraph.clinicalgenome.org/r/f8b97ec8-f6c8-4e15-832c-19fb2c70ada3v1.0","type":"EvidenceStrengthAssertion","dc:description":"","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/f8b97ec8-f6c8-4e15-832c-19fb2c70ada3","GCISnapshot":"https://genegraph.clinicalgenome.org/r/ae6ffeae-9609-47bf-89a9-4863cf6ef05c","calculatedEvidenceStrength":"NoKnownDiseaseRelationship","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/ae6ffeae-9609-47bf-89a9-4863cf6ef05c_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10063","date":"2020-10-05T16:19:49.076Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/ae6ffeae-9609-47bf-89a9-4863cf6ef05c_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10063","date":"2020-10-05T16:19:30.420Z","role":"Approver"}],"curationReasonDescription":"","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ae6ffeae-9609-47bf-89a9-4863cf6ef05c_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ae6ffeae-9609-47bf-89a9-4863cf6ef05c_ad_other_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/20fabf82-0211-4702-95be-7605e32b194e_proband_score_evidence_line","type":"EvidenceLine","dc:description":"It has not been published in the English literature whether in that same family MFN2 was later excluded to carry another mutation additionally to the one in KIF1B. Other families with a CMT2 phenotype and a linkage-analysis matching the CMT2A locus did not have mutations in KIF1B. The panel therefore decided not to give score points to this variant.","calculatedScore":0.5,"direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0e71cc98-c36f-402b-9612-ed8794933619","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11389829","rdfs:label":"IV-1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":7,"detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Linkage analysis","phenotypeFreeText":"Pes cavus, Hammertoe, Distal amyotrophy, Steppage gait, Distal muscle weakness, Foot dorsiflexor weakness, Areflexia, Decreased number of peripheral myelinated nerve fibers","phenotypes":["obo:HP_0001761","obo:HP_0001284","obo:HP_0002460","obo:HP_0001765","obo:HP_0009027","obo:HP_0003376","obo:HP_0003380","obo:HP_0003693"],"previousTesting":true,"previousTestingDescription":"linkage analysis inlcuding markers associated with the loci for CMT2A, CMT2B, and CMT2D","secondTestingMethod":"PCR","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/20fabf82-0211-4702-95be-7605e32b194e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11389829","allele":{"id":"https://genegraph.clinicalgenome.org/r/81edc2a7-5d11-4fa3-bc5a-1663fd393a63","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015074.3(KIF1B):c.293A>T (p.Gln98Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA253243"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallAutosomalDominantOtherVariantEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/ae6ffeae-9609-47bf-89a9-4863cf6ef05c_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a5b4f7b9-3888-4ff8-b19c-c9c35db1195c_proband_segregation","type":"FamilyCosegregation","dc:description":"This LOD score has been calculated based on linkage analysis. Another gene, MFN2, is, however, also included by these markers. The authors have never excluded an underyling variant in MFN2 in this family, which is why the expert panel decided not to score this family evidence.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11389829","rdfs:label":"JPN694","family":{"id":"https://genegraph.clinicalgenome.org/r/a5b4f7b9-3888-4ff8-b19c-c9c35db1195c","type":"Family","rdfs:label":"JPN694","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/0e71cc98-c36f-402b-9612-ed8794933619"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"Pes cavus, Hammertoe, Distal amyotrophy, Steppage gait, Distal muscle weakness, Foot dorsiflexor weakness, Areflexia, Decreased number of peripheral myelinated nerve fibers","phenotypePositiveAllelePositive":4,"phenotypes":["obo:HP_0002460","obo:HP_0001765","obo:HP_0003380","obo:HP_0001761","obo:HP_0001284","obo:HP_0009027","obo:HP_0003376","obo:HP_0003693"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/0e71cc98-c36f-402b-9612-ed8794933619"},"publishedLodScore":2.01}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/ae6ffeae-9609-47bf-89a9-4863cf6ef05c_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ae6ffeae-9609-47bf-89a9-4863cf6ef05c_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f08ad607-a732-406a-9c07-6459c06c2103","type":"EvidenceLine","dc:description":"Score reduced due to morpholino- instead of stable knockdown.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/45ec32ff-96f7-4be6-ada7-ced2f580f121","type":"Finding","dc:description":"Antisense morpholino oligonucleotide (MO) knockdown of the common start region of kif1b and blocking a splice junction specific to kif1b β cause truncation of the posterior lateral line nerve and a reduced axonal outgrowth in spinal cord motoneurons.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19503091","rdfs:label":"Morpholino knockdown of KIF1B in zebrafish","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/3dbe5a4e-850a-4d94-bb6e-d6bfe819768c","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7d40a7d7-53cd-46d1-aca3-ef07dc6fd99b","type":"Finding","dc:description":"-Newborn KIF1B-/- pups have insensitive to pinching, lordotic body posture, dropping forelimbs. There is a significantly reduced density of synaptic vesicles of the nerve terminals in anterior horn areas of the spinal cord in KIF1B -/- mice.\n-In KIF1B+/- mice, sciatic nerves show a reduced synaptic protein content and reduced synaptic transport at 2 months.\n-KIF1B +/- mice have an axonal neuropathy phenotype with distal weakness, balance disturbances, and reduced amplitutes in nerve conduction studies at 12 months. Comparably to the Gln98Leu(het) family described in this paper (JPN694), there was no distinct sensory loss (heat plate) in heterozygous KO mice.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11389829","rdfs:label":"Homozygous and heterozygous knockout","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/8b1a04f6-0a01-490f-bbec-00442d81f190","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/18d6da11-cad9-495e-84eb-58651c16e783","type":"Finding","dc:description":"Infection with KIF1Bβ, but not KIF1Bα expressing virus, significantly rescued the viability of kif1B−/− neurons.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11389829","rdfs:label":"Rescue Experiment of Hippocampal Neurons","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityCellCultureRescueCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/ae6ffeae-9609-47bf-89a9-4863cf6ef05c_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/075c0922-5738-4e0b-90bb-efd73237fd1e","type":"EvidenceLine","dc:description":"This functional evidence adds to the clinical evidence of the variant and cannot be additionally scored.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/acc9afce-aafc-4b0b-928c-ca8289481763","type":"FunctionalAlteration","dc:description":"Immunofluorescence of Vero cells showed a disturbed accumulation of KIF1B protein for the mutant: Due to its motility toward the plus ends of the microtubules, overexpressed wild-type KIF1Bβ protein accumulated at the cell periphery. In contrast, the Q98L mutant protein remained and aggregated in the perinuclear region.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11389829","rdfs:label":"Immunofluorescence of KIF1B in Vero cells"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/ae6ffeae-9609-47bf-89a9-4863cf6ef05c_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9c991d43-1d10-439d-ad99-dc8290431544","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/da6f986d-5fb1-4721-8012-46b8a4e199b4","type":"Finding","dc:description":"Disturbances of axonal transport and reduced axonal outgrowth are typical pathomechanisms of axonal neuropathies.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30126838","rdfs:label":"Fluorescent micrograph of cultured mouse hippocampal neurons","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/c1239961-c9a6-4ca4-96a5-faf0d80bcadb","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/976d927c-0bc1-4117-bb26-d4f2015f551d","type":"Finding","dc:description":"All genes are involved in axonal transport and cause neuropathy if mutated.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11389829","rdfs:label":"Immuno electron microscopy, floatation assay","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":5}],"evidenceStrength":"NoKnownDiseaseRelationship","sequence":1283,"specifiedBy":"GeneValidityCriteria7","strengthScore":5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/BmoDHmg2Zrk","type":"GeneValidityProposition","disease":"obo:MONDO_0007308","gene":"hgnc:16636","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_ae6ffeae-9609-47bf-89a9-4863cf6ef05c-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}